Trial · NCT06897553
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Depression and Anxiety Stress Scales-21 (Lovibond, 1995) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of psychological burden to investigate efficacy. Scores range from 0 to 63 with higher values indicating higher burden. |
| Primary | Acceptance and Action Questionnaire-Acquired Brain Injury (Sylvester, 2011) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of psychological flexibility to investigate efficacy. Scores range from 0 to 36 with higher values indicating higher inflexibility. |
| Primary | Wechsler Adult Intelligence Scale - Fourth Edition (Similarities subtest; Wechsler, 2008) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of individual's ability to recognize and articulate the commonalities between different objects, reflecting their abstraction ability. This will be used to examine the influence of the ability of abstract thinking. Scores range from 0 to 36 with higher values indicating higher ability of abstraction. |
| Secondary | Patient Health Questionnaire-9 (Kroenke, 2001) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of depressive symptoms to investigate efficacy. Scores range from 0 to 27 with higher values indicating more severe depressive symptoms. |
| Secondary | Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer et al., 2007) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of anxiety symptoms to investigate efficacy. Scores range from 0 to 21 with higher scores indicating higher anxiety. |
| Secondary | Valuing Questionnaire (Smout, 2014) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of valued living to investigate efficacy. Scores range from 0 to 60 with higher values indicating higher value-congruent living. |
| Secondary | Self-as-context scale (Zettle, 2018) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of self as context to investigate efficacy. Scores range from 10 to 70 with higher values indicating a perspective closer to self-as-context. |
| Secondary | World Health Organization Disability Assessment Schedule 2.0 (V.S. Üstün, 2010; Plain German) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of functional impairments and disabilities. |
| Secondary | Regensburg Word Fluency Test (Aschenbrenner, 2001) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of verbal fluency. |
| Secondary | Stroop Test in Vienna Test System (Müller & Ziegler, 2001) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of cognitive flexibility and inhibition of irrelevant stimuli. |
| Other | Group therapy session questionnaire (Zoubek, 2013; Plain German) | GTS-P Session and GTS-T during the intervention (weekly, after each session), GTS-P Total post-intervention | Measure of treatment acceptance and satisfaction for patients regarding each session (GTS-P Session), for patients regarding the entire therapy (GTS-P Total), and for therapists regarding the each session (GTS-T). GTS-P Session scores from 0 to 24 with higher values indicating higher acceptance. GTS-P Total scores from 0 to 8 with higher values indicating higher acceptance. GTS-T scores from 0 to 48 with higher values indicating higher acceptance. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06897553/registered